Opthea Ltd.

Biotechnology • Healthcare • Melbourne, VIC, United States • CKDXF (PNK)

Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.

61 3 9826 0399 Level 9, Melbourne, VIC 3000, Australia

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

$680M Liability Settled for Just $20M: Biotech Opthea Survives Trial Failure with Major Restructuring - Stock Titan

Stock Titan • Aug 18

Opthea to lay off 80% of workforce amid executive cuts - Eyes On Eyecare

Eyes On Eyecare • Aug 19

Opthea Grants 41 Million Options to Non-Executive Director Katherine Connell - TipRanks

TipRanks • Dec 22

Opthea discontinues COAST and ShORe trials in wet AMD - Ophthalmology Times

Ophthalmology Times • Mar 31

Opthea's eye disease drug defeated by Eylea in phase 3, leaving biotech to mull future - Fierce Biotech

Fierce Biotech • Mar 24

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Opthea Ltd had layoffs?

No layoff events have been recorded for Opthea Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Opthea Ltd in?

Opthea Ltd operates in the Biotechnology industry, within the Healthcare sector.

Is Opthea Ltd a publicly traded company?

Yes, Opthea Ltd is publicly traded under the ticker symbol CKDXF on the PNK. The company has a market capitalization of approximately $0.60 billion.

Where is Opthea Ltd headquartered?

Opthea Ltd is headquartered in Melbourne, VIC, United States at Level 9, Melbourne, VIC 3000, Australia.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.